Introducing micro physiological systems to evaluate new radiopharmaceuticals: A binding study with radiolabeled cetuximab
Radiopharmaceuticals can be used for targetspecific functional diagnostics, such as PET or SPECT imaging, or radionuclide therapy of diseased tissue, depending on the incorporated radionuclide. Following initial in vitro testing, radiopharmaceutical candidates are usually further characterized in sm...
Main Authors: | Sihver Wiebke, Nitt-Weber Anne-Kathrin, Behrens Stephan, Ullrich Martin, Pietzsch Hans-Jürgen, Namazian Jam Negin, Schmieder Florian, Sonntag Frank |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2022-09-01
|
Series: | Current Directions in Biomedical Engineering |
Subjects: | |
Online Access: | https://doi.org/10.1515/cdbme-2022-1136 |
Similar Items
-
Pharmacokinetic Studies of Radiopharmaceuticals
by: A. S. Lunev, et al.
Published: (2022-12-01) -
The Recent Research Development of 177Lu Radiopharmaceuticals
by: YANG Yuchuan;KAN Wentao;YANG Xia;WEI Hongyuan;ZHUO Liangang;WANG Jing;LIAO Wei;ZHAO Peng;WANG Guanquan
Published: (2022-06-01) -
Radiopharmaceutical Validation for Clinical Use
by: Charles A. Kunos, et al.
Published: (2021-03-01) -
Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy
by: Wiebke Sihver, et al.
Published: (2014-03-01) -
Methodological Approaches to Preclinical Evaluation of General Toxicity of Therapeutic Radiopharmaceuticals
by: O. E. Klementyeva, et al.
Published: (2021-12-01)